Catalent | CTLT - Pasivo Circulante



Pasivo Circulante Cambio Fecha
Agilent USD 2.23B 113M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Bruker USD 1.28B 11.1M 2025-12
Centene USD 36.7B 3.93B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Elevance Health USD 41.04B 157M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Hologic USD 951.3M 25.9M 2025-12
Humana USD 16.35B 166M 2025-12
Illumina USD 1.59B 377M 2025-12
Intuitive Surgical USD 2.52B 207.3M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
J&J USD 54.13B 3.26B 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Lonza CHF 3.58B 970M 2024-12
McKesson USD 68.13B 100M 2025-12
Merck EUR 8.64B 1.22B 2025-09
Merck USD 28.63B 2.59B 2025-09
Mettler Toledo International USD 1.2B 5.99M 2025-12
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Quest Diagnostics USD 2.28B 144M 2025-12
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Roche Holding CHF 28B 421M 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
UnitedHealth USD 115.53B 4.74B 2025-09
Veradigm USD 253.09M 3.24M 2022-09
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12